Interim analysis of a phase II study of nivolumab/ipilimumab plus cabozantinib in patients with unresectable advanced melanoma - Pecora, Andrew L; Rapisuwon, Suthee; Chen, Kevin; Gardner, Kellie; Cramer, Gayle; Blair, Danielle; Avergas, Amy; Swanson, Nicole; Ahn, Jaeil; Atkins, Michael B. (Journal of clinical oncology, 2023)